Primary Record
ziftomenib
- In stock
- 2,160 g
- Purity
- 99.8 %
- CAS
- 2134675-36-6
Compound Identifiers & Properties
- CAS
- 2134675-36-6
- PubChem CID
- 138497449
- SMILES
- CC1=C(C=CC2=C1C=C(N2C[C@H](C)N3CCN(CC3)S(=O)(=O)C)C#N)CN4CCC(CC4)NC5=C6C=C(SC6=NC(=N5)NC)CC(F)(F)F
- Canonical SMILES
- CNc1nc(NC2CCN(Cc3ccc4c(cc(C#N)n4C[C@H](C)N4CCN(S(C)(=O)=O)CC4)c3C)CC2)c2cc(CC(F)(F)F)sc2n1
Names & Synonyms
- ziftomenib
- Komzifti
- UNII-4MOD1F4ENC
- Ziftomenib [USAN]
- 4MOD1F4ENC
- Komzifti (TN)
- KO-539
- 2134675-36-6
- KO539
- ZIFTOMENIB [INN]
- KO-539;ziftomenibum
- Ziftomenib [WHO-DD]
- RefChem:195960
- Ziftomenib (USAN/INN)
- Ko 539
- Menin-MLL Inhibitor KO-539
- orb1691203
- CHEMBL5095038
- KO 539 [WHO-DD]
- SCHEMBL20846943
- SCHEMBL30456063
- GTPL11680
- YQF2714
- BGGALFIXXQOTPY-NRFANRHFSA-N
- Menin-KMT2A Inhibitor KO 539
- MFCD34574446
- WHO 11651
- GLXC-26507
- EX-A5611
- compound 151 [US10781218B2]
- Menin-mll interaction inhibitor KO 539
- NSC853767
- AKOS040757323
- NSC-853767
- compound 151 (US10781218B2)
- AC-38409
- DA-79103
- MS-31220
- SY412664
- HY-132001
- CS-0146342
- D12419
- G18455
- A949460
- 4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]-1-[(2S)-2-(4-methylsulfonylpiperazin-1-yl)propyl]indole-2-carbonitrile
- (S)-4-Methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile
- Menin-Mixed Lineage Leukemia Protein-Protein Interaction Inhibitor KO 539
- (S)-4-Methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile
- (7S)-8-(methanesulfonyl)-5,7-dimethyl-1(2)-(methylamino)-1-(2,2,2-trifluoroethyl)-2-aza-1(4)-thieno[2,3-d]pyrimidina-5(5,1)-indola-8(1)-piperazina-3(4,1)-piperidinaoctaphane-5(2)-carbonitrile
- (S)-4-Methyl-5-((4-(2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile
- (S)-4-Methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidyl]methyl]-1-[2-[4-(methylsulfonyl)-1-piperazinyl]propyl]indole-2-carbonitrile
- 1H-INDOLE-2-CARBONITRILE, 4-METHYL-5-((4-((2-(METHYLAMINO)-6-(2,2,2-TRIFLUOROETHYL)THIENO(2,3-D)PYRIMIDIN-4-YL)AMINO)-1-PIPERIDINYL)METHYL)-1-((2S)-2-(4-(METHYLSULFONYL)-1-PIPERAZINYL)PROPYL)-
- 1H-Indole-2-carbonitrile, 4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1-[(2S)-2-[4-(methylsulfonyl)-1-piperazinyl]propyl]-
- 4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-((2S)-2-(4-methylsulfonylpiperazin-1-yl)propyl)indole-2-carbonitrile
- 4-Methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1-[(2S)-2-[4-(methylsulfonyl)-1-piperazinyl]propyl]-1H-indole-2-carbonitrile
- K5O